Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

FDA Approves Subcutaneous Herceptin Formulation for HER2-positive Breast Cancer

February 28th 2019, 11:01pm

Article

The FDA has approved subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy for the treatment of select patients with HER2-positive early breast cancer.

Jumping Into a Cancer Conference

January 30th 2019, 7:20pm

Article

Meeting others, learning tips, hearing from docs: breast cancer patients have it all when they get together.

You Can Improve Cancer Care

January 11th 2019, 7:33pm

Article

Three ways this metastatic breast cancer patient has made research participation a part of her life.

Plan B For The New Year

January 3rd 2019, 7:20pm

Article

Real resolutions to make 2019 feel like a year of finally putting away unachievable goals from the past.

CURE's Top 5 Stories: December 2018

January 1st 2019, 8:00pm

Article

Here are the top 5 CURE stories for December 2018.

Loss, Love and Metastatic Cancer

December 14th 2018, 9:00pm

Article

Cancer has led me to men and women who grabbed onto life but died anyway.

My Month Of Scanxiety

December 9th 2018, 11:20pm

Article

Four years' worth of high-stakes scans have made me an expert in four excellent ways to ease intense anxiety.

Stumbling Through The Holidays

December 4th 2018, 7:16pm

Article

Emotions are not an either/or proposition when it comes to metastatic cancer.

'Setting the Stage' in Breast Cancer

November 2nd 2018, 9:30pm

Article

Additional factors now help determine a breast cancer’s stage, making prognoses more accurate.

Turning Up The Volume

October 30th 2018, 9:10pm

Article

Metastatic breast cancer advocate goes to Washington DC to tell her own story and push for more research to be directed toward metastatic disease